This appears to be a replacement to the scalpel as known today. Less bleeding and better control are some of the benefits for surgeons. This gives the best of both worlds to the surgeon it appears. Other devices on the market also control bleeding but potentially cause additional tissue...
The cardiovascular point of care tests will be marketed by Roche Diagnostics. The test will located elevated levels of the markers for BNP, which are indicators for heart failure. A very sophisticated technology that will allow for hospitals to check with a simple test to see if a patient...